OVB.L

Ovoca Bio plc [OVB.L] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

OVB.L Stock Summary

Top 10 Correlated ETFs

OVB.L

Top 10 Correlated Stocks

OVB.L

In the News

OVB.L Financial details

Company Rating
-
Market Cap
540.85K
Income
-3.01M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
5
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.15
Forward P/E
-
PEG
0.03
P/S
-
P/B
0.11
P/C
-
P/FCF
-0.15
Quick Ratio
2.09
Current Ratio
2.81
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
2.08%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-6475%
-
-
-
-
SMA20
-8.03%
SMA50
-11.89%
SMA100
-22.22%
Inst Own
-
Inst Trans
-
ROA
-60%
ROE
-53%
ROC
-0.73%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.451-14.8
52W High
-
52W Low
-
RSI
24.59
Rel Volume
4.31
Avg Volume
119.97K
Volume
516.97K
Perf Week
1.6%
Perf Month
-9.29%
Perf Quarter
-29.44%
Perf Half Y
-23.03%
-
-
-
-
Beta
0.728
-
-
Volatility
0.01%, 0.06%
Prev Close
0%
Price
1.27
Change
0%

Something similar

Top by Market Cap
AVGO
LLY.SW
META
AMZ.DE
FB2A.DE
Top Correlated ETFs
ESGB.TO
VGEM.DE
SYBM.DE
UEFE.DE
SBEM.L
Top Correlated Stocks
CPP.L
6MK.DE
PFE.DE
0H6E.L
SUGA.L
Similar Market Cap
CANB
VISM
GBGR
BYOT.L
EMPW

Company Profile

Healthcare Biotechnology
  • Volume Average 119.97K
  • Market Capitalization 540.85K
  • Employee 5
  • CEO Mr. Kirill Andreyevich Golovanov
  • Headquarters Dublin,IE
  • IPO Date 2000-01-04
  • Website https://ovocabio.com

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.